(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.04%) $0.927
(0.26%) $10.87
(0.08%) $0.793
(-0.31%) $92.29
Live Chart Being Loaded With Signals
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States...
Stats | |
---|---|
Today's Volume | 1.47M |
Average Volume | 525 508 |
Market Cap | 83.37M |
EPS | $0 ( 2024-03-28 ) |
Next earnings date | ( $-0.100 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.36 |
ATR14 | $0.00500 (0.54%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Ward Shane | Buy | 120 000 | Common Stock |
2024-03-15 | Ward Shane | Buy | 250 000 | Employee Stock Option (right to buy) |
2024-03-15 | Shah Preetam | Buy | 108 750 | Common Stock |
2024-03-15 | Shah Preetam | Buy | 217 500 | Employee Stock Option (right to buy) |
2024-03-15 | Tari Leslie | Buy | 111 250 | Common Stock |
INSIDER POWER |
---|
89.27 |
Last 100 transactions |
Buy: 7 175 633 | Sell: 576 273 |
Volume Correlation
Cidara Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
MESA | 0.902 |
ATHX | 0.885 |
CTIB | 0.882 |
IGTA | 0.876 |
HLIO | 0.873 |
IOBT | 0.859 |
XLNX | 0.857 |
TITN | 0.855 |
KZR | 0.854 |
AZYO | 0.853 |
10 Most Negative Correlations | |
---|---|
NTUS | -0.89 |
DVCR | -0.876 |
OPNT | -0.869 |
JJSF | -0.867 |
SVOK | -0.866 |
LMNX | -0.861 |
PROC | -0.856 |
STAY | -0.852 |
DSPG | -0.843 |
MSON | -0.842 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cidara Therapeutics Inc Correlation - Currency/Commodity
Cidara Therapeutics Inc Financials
Annual | 2022 |
Revenue: | $64.29M |
Gross Profit: | $64.15M (99.78 %) |
EPS: | $-0.430 |
Q3 | 2023 |
Revenue: | $12.72M |
Gross Profit: | $12.33M (96.96 %) |
EPS: | $-0.0905 |
Q2 | 2023 |
Revenue: | $7.61M |
Gross Profit: | $7.21M (94.73 %) |
EPS: | $-0.140 |
Q1 | 2023 |
Revenue: | $25.99M |
Gross Profit: | $25.67M (98.77 %) |
EPS: | $0.0250 |
Financial Reports:
No articles found.
Cidara Therapeutics Inc
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators